documents: FDA-2019-D-5473-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2019-D-5473-0001 FDA FDA-2019-D-5473 Promotional Labeling and Advertising Considerations for Prescription Biological Reference and Biosimilar Products—Questions and Answers; Draft Guidance for Industry; Availability Notice Notice of Availability 2020-02-04T05:00:00Z 2020 2 2020-02-04T05:00:00Z 2020-04-07T03:59:59Z 2020-02-23T21:50:39Z 2020-02100 0 0 0900006484325636

Links from other tables